KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Invested Capital (2018 - 2025)

Historic Invested Capital for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $560.0 million.

  • Progyny's Invested Capital rose 2877.33% to $560.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.0 million, marking a year-over-year increase of 2877.33%. This contributed to the annual value of $422.1 million for FY2024, which is 2373.69% down from last year.
  • Latest data reveals that Progyny reported Invested Capital of $560.0 million as of Q3 2025, which was up 2877.33% from $515.0 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's Invested Capital peaked at $571.6 million during Q1 2024, and registered a low of $184.6 million during Q1 2021.
  • Moreover, its 5-year median value for Invested Capital was $424.4 million (2023), whereas its average is $398.4 million.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 7609.53% in 2021, then crashed by 2373.69% in 2024.
  • Over the past 5 years, Progyny's Invested Capital (Quarter) stood at $251.8 million in 2021, then soared by 49.7% to $377.0 million in 2022, then skyrocketed by 46.81% to $553.4 million in 2023, then dropped by 23.74% to $422.1 million in 2024, then surged by 32.68% to $560.0 million in 2025.
  • Its last three reported values are $560.0 million in Q3 2025, $515.0 million for Q2 2025, and $467.2 million during Q1 2025.